1. Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences,Anhui,Hefei,China,230031
2. Science Island Branch, Graduate School of University of Science and Technology of China,Anhui,Hefei,China,230026
3. Medical Pathology Center, Hefei Cancer Hospital, Chinese Academy of Sciences,Anhui,Hefei,China,230031
4. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China,Anhui,Hefei,China,230001
5. Department of Pathology, The First Affiliated Hospital of Anhui Medical University,Anhui,Hefei,China,230601
Qianwen Cui, Jiarong Zhao, Qingmei Deng, et al. HMGB3 is a potential diagnostic marker for early cervical lesion screening. [J]. Genes & Diseases 1(6):2202-2205(2023)
DOI:
Qianwen Cui, Jiarong Zhao, Qingmei Deng, et al. HMGB3 is a potential diagnostic marker for early cervical lesion screening. [J]. Genes & Diseases 1(6):2202-2205(2023) DOI: 10.1016/j.gendis.2023.02.033.
HMGB3 is a potential diagnostic marker for early cervical lesion screening
摘要
Abstract
关键词
Keywords
references
1 M. Zheng, L. Hou, Y. Ma, et al.Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors Mol Cancer, 18 (1) (2019), p. 76
2 W. Chantima, C. Thepthai, P. Cheunsuchon, et al.EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM BMC Cancer, 17 (1) (2017), p. 811
3 B. Umphress, B. Sanchez, A. Paintal, et al.Utility of CK7 versus P16 as a prognostic biomarker in CIN 2 Am J Surg Pathol, 42 (4) (2018), pp. 479-484
4 S. Wong, W. Hong, P. Hui, et al.Comprehensive analysis of PAX8 expression in epithelial malignancies of the uterine cervix Int J Gynecol Pathol, 36 (2) (2017), pp. 101-106
5 J. Kaur, P. Dey, S.C. Saha, et al.Cervical cytology in patients with postmenopausal bleeding Diagn Cytopathol, 38 (7) (2010), pp. 496-498